Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Iron deficiency might be linked to hair loss, but more research is needed.

PRP is a versatile and affordable treatment for improving appearance in the elderly, with patient needs and expectations being important.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Low-glycemic index diets are beneficial for weight loss and satiety, but more research is needed on long-term effects and individualized approaches are recommended.

Preparing and learning about menopause can improve women's quality of life as they approach this phase.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

The document concludes that more research is needed to understand how PRP affects the ovaries and to standardize its use in treatment.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Androgens can both increase and decrease hair growth in different parts of the body.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.